Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?
Oruka Therapeutics Ownership Summary
Oruka Therapeutics is owned by 14.81% institutional investors, 2.95% insiders, and 82.24% retail investors. Fmr is the largest institutional shareholder, holding 17.18% of ORKA shares.
ORKA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Oruka Therapeutics | 14.81% | 2.95% | 82.24% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 7.26M | 17.18% | $139.56M |
| Vr adviser | 4.15M | 9.82% | $79.77M |
| Fairmount funds management | 3.71M | 8.77% | $71.25M |
| Viking global investors lp | 2.67M | 6.31% | $51.28M |
| Deep track capital, lp | 2.65M | 6.29% | $51.05M |
| Blackrock funding, inc. /de | 2.20M | 5.22% | $42.39M |
| Rtw investments, lp | 1.95M | 4.61% | $37.41M |
| Vanguard group | 1.78M | 4.21% | $34.17M |
| Commodore capital lp | 1.75M | 4.15% | $33.71M |
| Braidwell lp | 1.38M | 3.27% | $26.58M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fairmount funds management | 3.71M | 6.41% | $71.25M |
| Vr adviser | 4.15M | 4.49% | $79.77M |
| Cable car capital | 500.00K | 4.12% | $9.62M |
| Avidity partners management lp | 660.42K | 2.89% | $12.70M |
| Commodore capital lp | 1.75M | 1.65% | $33.71M |
| Affinity asset advisors | 959.18K | 1.61% | $18.45M |
| Great point partners | 183.33K | 1.45% | $3.53M |
| Deep track capital, lp | 2.65M | 1.42% | $51.05M |
| Sr one capital management, lp | 430.33K | 1.20% | $8.28M |
| B group | 75.00K | 1.06% | $1.44M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Viking global investors lp | 2.67M | 0.13% | 2.67M |
| Fmr | 7.26M | 0.01% | 1.64M |
| Avoro capital advisors | 1.33M | 0.33% | 1.33M |
| Perceptive advisors | 1.27M | 0.70% | 1.27M |
| Deep track capital, lp | 2.65M | 1.42% | 735.98K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | - | - | -849.41K |
| Paradigm biocapital advisors lp | - | - | -819.66K |
| Frazier life sciences management | - | - | -583.33K |
| Redmile group | - | - | -386.96K |
| Driehaus capital management | - | - | -308.80K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Viking global investors lp | 2.67M | 0.13% | 2.67M | $51.28M |
| Avoro capital advisors | 1.33M | 0.33% | 1.33M | $25.64M |
| Perceptive advisors | 1.27M | 0.70% | 1.27M | $24.38M |
| Cormorant asset management, lp | 533.34K | 0.71% | 533.34K | $10.26M |
| Great point partners | 183.33K | 1.45% | 183.33K | $3.53M |
Sold Out
| Holder | Change |
|---|---|
| Coldstream capital management | -180.00 |
| Artia global partners lp | -7.38K |
| Renaissance | -13.90K |
| Jane street group | -17.71K |
| Cannon global investment management | -19.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 42 | -48.15% | 6,253,192 | -81.84% | 14 | 0.22% | 25 | -51.92% | 9 | -35.71% |
| Jun 30, 2025 | 80 | 17.65% | 34,421,525 | 22.70% | 81 | 1.80% | 53 | 20.45% | 14 | 27.27% |
| Mar 31, 2025 | 70 | 7.69% | 31,776,535 | 2.46% | 76 | 1.28% | 44 | -8.33% | 11 | 37.50% |
| Dec 31, 2024 | 66 | 57.14% | 31,038,321 | 26.38% | 77 | 0.29% | 49 | 16.67% | 8 | - |
| Sep 30, 2024 | 42 | - | 24,559,501 | - | 163 | - | 42 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $1.02M |
| Feb 13, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $173.87K |
| Feb 12, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $106.40K |
| Feb 11, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $105.04K |
| Feb 10, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $6.26K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 5 | - |
| 2024 Q4 | - | - |
ORKA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools